CFOQUEST® Product Monograph, Elvium Life Sciences,
September 28, 2022.
CADDRA - Canadian ADHD Resource Alliance: Canadian ADHD Practice
Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.
Weiss MD, et al. Efficacy and safety of a long-acting multilayer-release
methylphenidate formulation (PRC-063) in the treatment of adolescent
Attention-Deficit/Hyperactivity Disorder: a randomized, double-blind clinical
trial with a 6-Month open-label extension. J Child Adolesc
Psychopharmacol
2021;31(9):610-622.
Weiss MD, et al. Efficacy and safety of PRC-063, extended-release multilayer
methylphenidate in adults with ADHD including 6-month open-label extension.
J Attent Disor 2021;25(10):1417-1428.
CBiphentin® Product Monograph, Elvium Life Sciences,
September 2, 2021.
CConcerta® Product Monograph, Janssen Inc., May 13, 2022.
Wigal SB, et al. Reliability and validity of the SKAMP rating scale in a
laboratory
school setting. Psychopharmacol Bull 1998;34(1):47-53.
Reiz JL, et al. Comparative bioavailability of single-dose methylphenidate
from a multilayer-release bead formulation and an osmotic system A two-way crossover study in healthy
young adults. Clin Ther 2008;30(1):59-69.